Evidence map›Paper›PMID 41636204›Full record

ArticleEuropean journal of immunology2026

UBL3 Participates in the Early Stages of CD83-Dependent CD4

Huw Morgan, Haiyin Liu, Jose A Villadangos, Justine D Mintern

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Huw MorganDepartment of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia.ORCID 0000-0001-9132-8738
Haiyin LiuDepartment of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia.
Jose A VilladangosDepartment of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia.
Justine D MinternDepartment of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia.

Funding

National Health and Medical Research Council, Australia APP1161101University of Melbourne Cytometry Platform
6 · The paper itself

Abstract

CD83 is critical for CD4

Indexed as

Antigens, CDCD4-Positive T-LymphocytesImmunoglobulinsMembrane GlycoproteinsUbiquitinsAnimalsCD83 AntigenEpithelial CellsHistocompatibility Antigens Class IIMiceMice, Inbred C57BLMice, KnockoutThymus GlandAntigens, CDCD83 AntigenHistocompatibility Antigens Class IIImmunoglobulinsMembrane GlycoproteinsUbiquitins

Identifiers

PMID41636204
PMCPMC12869844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.